Access to healthcare services for people with non-communicable diseases during the COVID-19 pandemic in Ibadan, Nigeria: a qualitative study.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
09 Nov 2023
Historique:
received: 12 07 2023
accepted: 06 11 2023
medline: 13 11 2023
pubmed: 10 11 2023
entrez: 10 11 2023
Statut: epublish

Résumé

Desirable outcomes for people with non-communicable diseases (NCDs) are achieved when they access routine monitoring and care services. Expectedly, the COVID-19 pandemic severely impacted access to healthcare services, leading to poor health outcomes among people with NCDs. We aimed to [1] explore the delays in accessing healthcare services and [2] understand alternative actions adopted by people with NCDs to overcome these delays. We conducted an exploratory qualitative research guided by the "Three Delays" model to unpack the barriers to healthcare access for people living with NCDs in Ibadan, Nigeria. The "Three Delays" model conceptualizes the reasons for negative/adverse healthcare outcomes related to the patient's decision-making to seek healthcare, reaching an appropriate healthcare facility, and receiving adequate care at the healthcare facility. Twenty-five (25) people with NCDs were purposively selected from the University College Hospital's medical outpatient department to participate in in-depth interviews. Interview recordings were transcribed verbatim and analyzed using a deductive-inductive hybrid thematic analysis. At the level of individual decision-making, delays were related to fear of contracting COVID-19 in the hospital (considered a hotspot of the COVID-19 pandemic). Regarding reaching an appropriate healthcare facility, delays were mainly attributed to the intra- and inter-city lockdowns, limiting the movements of persons. For those who successfully arrived at the healthcare facilities, delays were related to the unavailability of healthcare professionals, prioritization of COVID-19 patients, and mandatory adherence to COVID-19 protocols, including COVID-19 testing. To overcome the delays mentioned above, people with NCDs resorted to (i) using private healthcare facilities, which were more costly, (ii) using virtual consultation through mobile phone Apps and (iii) self-management, usually by repeating previously prescribed prescriptions to obtain medication. Pandemic conditions provide unique challenges to people with chronic illnesses. Recognizing the need for continuous access to monitoring and care services under such conditions remains critical. Alternative health service provision approaches should be considered in pandemic situations, including remote healthcare services such as Mobile health apps (mHealth) that can help manage and prevent NCDs.

Sections du résumé

BACKGROUND BACKGROUND
Desirable outcomes for people with non-communicable diseases (NCDs) are achieved when they access routine monitoring and care services. Expectedly, the COVID-19 pandemic severely impacted access to healthcare services, leading to poor health outcomes among people with NCDs. We aimed to [1] explore the delays in accessing healthcare services and [2] understand alternative actions adopted by people with NCDs to overcome these delays.
METHODS METHODS
We conducted an exploratory qualitative research guided by the "Three Delays" model to unpack the barriers to healthcare access for people living with NCDs in Ibadan, Nigeria. The "Three Delays" model conceptualizes the reasons for negative/adverse healthcare outcomes related to the patient's decision-making to seek healthcare, reaching an appropriate healthcare facility, and receiving adequate care at the healthcare facility. Twenty-five (25) people with NCDs were purposively selected from the University College Hospital's medical outpatient department to participate in in-depth interviews. Interview recordings were transcribed verbatim and analyzed using a deductive-inductive hybrid thematic analysis.
RESULTS RESULTS
At the level of individual decision-making, delays were related to fear of contracting COVID-19 in the hospital (considered a hotspot of the COVID-19 pandemic). Regarding reaching an appropriate healthcare facility, delays were mainly attributed to the intra- and inter-city lockdowns, limiting the movements of persons. For those who successfully arrived at the healthcare facilities, delays were related to the unavailability of healthcare professionals, prioritization of COVID-19 patients, and mandatory adherence to COVID-19 protocols, including COVID-19 testing. To overcome the delays mentioned above, people with NCDs resorted to (i) using private healthcare facilities, which were more costly, (ii) using virtual consultation through mobile phone Apps and (iii) self-management, usually by repeating previously prescribed prescriptions to obtain medication.
CONCLUSION CONCLUSIONS
Pandemic conditions provide unique challenges to people with chronic illnesses. Recognizing the need for continuous access to monitoring and care services under such conditions remains critical. Alternative health service provision approaches should be considered in pandemic situations, including remote healthcare services such as Mobile health apps (mHealth) that can help manage and prevent NCDs.

Identifiants

pubmed: 37946244
doi: 10.1186/s12913-023-10278-0
pii: 10.1186/s12913-023-10278-0
pmc: PMC10636991
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1231

Informations de copyright

© 2023. The Author(s).

Références

Disaster Med Public Health Prep. 2021 Jun 08;:1-5
pubmed: 34099083
BMC Public Health. 2021 Apr 8;21(1):685
pubmed: 33832478
Soc Sci Med. 1994 Apr;38(8):1091-110
pubmed: 8042057
Am J Trop Med Hyg. 2021 Jun 23;105(2):323-330
pubmed: 34161296
Lancet HIV. 2021 Mar;8(3):e158-e165
pubmed: 33549166
Prim Care Diabetes. 2021 Dec;15(6):918-922
pubmed: 34393092
PLoS One. 2021 Nov 12;16(11):e0259822
pubmed: 34767594
BMJ Open. 2021 Mar 18;11(3):e045813
pubmed: 33737441
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
BMC Public Health. 2020 Aug 18;20(1):1258
pubmed: 32811462
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):917-920
pubmed: 32574982
Med Teach. 2020 Aug;42(8):846-854
pubmed: 32356468
Pan Afr Med J. 2020 Jul 04;35(Suppl 2):101
pubmed: 33282056
Int J Health Plann Manage. 2021 Jan;36(1):13-17
pubmed: 32857892
JMIR Hum Factors. 2022 Mar 2;9(1):e28697
pubmed: 35234653
Pan Afr Med J. 2020 Aug 11;35(Suppl 2):143
pubmed: 33193958
BMJ Open. 2023 Feb 2;13(2):e065901
pubmed: 36731928
BMC Health Serv Res. 2021 Jul 13;21(1):692
pubmed: 34256756
Risk Manag Healthc Policy. 2021 Oct 19;14:4353-4360
pubmed: 34703344
Qual Health Res. 2022 Jul;32(8-9):1328-1341
pubmed: 35621329
Am J Emerg Med. 2021 Jun;44:468-469
pubmed: 32303410
JMIR Mhealth Uhealth. 2018 Jul 13;6(7):e137
pubmed: 30006326
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Health Policy. 2021 Jul;125(7):869-876
pubmed: 33840478
Saudi Pharm J. 2022 Jul;30(7):927-933
pubmed: 35903533
Int J Gen Med. 2019 Nov 06;12:395-403
pubmed: 31819592
S Afr Med J. 2020 Jun 25;110(8):711-712
pubmed: 32880290
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Eur J Ageing. 2022 Apr 22;19(4):1243-1250
pubmed: 35474732
Glob Heart. 2021 Feb 04;16(1):9
pubmed: 33598389
Am J Trop Med Hyg. 2020 Oct;103(4):1630-1634
pubmed: 32815509
BMJ Glob Health. 2021 Aug;6(8):
pubmed: 34452941
J Am Pharm Assoc (2003). 2022 May-Jun;62(3):834-839.e1
pubmed: 34844885
Saudi Pharm J. 2020 Oct;28(10):1149-1154
pubmed: 32837218
PLoS One. 2021 Jul 29;16(7):e0255534
pubmed: 34324556
Reprod Health. 2021 Aug 4;18(1):166
pubmed: 34348757
BMC Public Health. 2021 Apr 10;21(1):704
pubmed: 33838676
Lancet Glob Health. 2019 Oct;7(10):e1295-e1296
pubmed: 31537347
Niger J Clin Pract. 2022 Jan;25(1):49-54
pubmed: 35046195

Auteurs

Lucia Yetunde Ojewale (LY)

Department of Nursing, University of Ibadan, Ibadan, Oyo State, Nigeria. luciayetunde@gmail.com.

Ferdinand C Mukumbang (FC)

Department of Global Health, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH